Pharmadrug Inc (PHRX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 09-2017 | 09-2016 | 09-2015 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 778 | N/A | N/A | 0 | 0 |
| Income taxes - deferred | -443 | N/A | N/A | N/A | N/A |
| Accounts receivable | -115 | 8 | 3 | 8 | 139 |
| Accounts payable and accrued liabilities | 591 | N/A | N/A | N/A | N/A |
| Other Working Capital | 395 | -476 | -18 | 107 | 181 |
| Other Operating Activity | -3,547 | -819 | -114 | -158 | -571 |
| Operating Cash Flow | $-2,340 | $-1,287 | $-130 | $-43 | $-251 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | N/A | N/A | -186 | -1,427 |
| Net Acquisitions | -7,085 | -403 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | -371 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -9 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -215 | 0 | 0 | 160 | 606 |
| Investing Cash Flow | $-7,319 | $-774 | $N/A | $-25 | $-820 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,000 | N/A | N/A | N/A | N/A |
| Debt Issued | 600 | N/A | N/A | N/A | N/A |
| Debt Repayment | -20 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 1,724 | 953 | 158 | N/A | 0 |
| Other Financing Activity | 4,206 | 821 | -40 | 30 | 0 |
| Financing Cash Flow | $9,510 | $1,773 | $118 | $30 | $0 |
| Exchange Rate Effect | 67 | -56 | N/A | N/A | N/A |
| Beginning Cash Position | 155 | 499 | 13 | 52 | 1,123 |
| End Cash Position | 74 | 155 | 1 | 13 | 52 |
| Net Cash Flow | $-149 | $-288 | $-12 | $-39 | $-1,071 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,340 | -1,287 | -130 | -43 | -251 |
| Capital Expenditure | -19 | N/A | N/A | -186 | -1,427 |
| Free Cash Flow | -2,359 | -1,287 | -130 | -229 | -1,678 |